Bpifrance is a financial institution dedicated to supporting companies throughout their development stages, particularly those preparing for stock market listing and seeking credit equity. The organization provides a range of financial solutions, including financing, innovation assistance, and capital investment. By integrating various entities such as OSEO and CDC Entreprises, Bpifrance aims to deliver tailored financial support that addresses the specific needs of businesses. The institution is committed to fostering innovation and helping companies transition toward sustainable growth, ensuring they are well-equipped to face future challenges.
Director of Transverse Venture Capital Investments Division
Benoit Barteau Ph.D
Investment Director
Nicolas Berdou
Investment Director, Defense Expert
Clarisse Blandin
Investment Director
Elyssa Maufras du Châtellier
Investment Director
Edouard Combette
Investment Director
Charlotte Corbaz
Investment Drector - Large Venture
Sofia Dahoune
Associate
Nicolas Dardenne
Senior Investment Director, Normandy (Caen Rouen)
Arnaud Despoisse
Director of Occitanie Participations
Nicolas Dufourcq
CEO
Mailys Ferrere
Director of Large Venture Investments
Romain Fourcade
Investment Director
Paul-Francois Fournier
Executive Director, Innovation Department
Vanessa Giraud
Director of Environmental Impact Funds
Alessandro Gonella
Director
Gwenael Hamon
Investment Director
Laurent Higueret
Senior Investment Director, Healthcare and Life Sciences - Large Venture Fund
Veronique Jacq
Head of Digital Venture team
Louis Janneau
Investment Director and Fund Manager
Magali Joessel
Director of Funds
So-Yeon Koo
Senior Investment Manager
Jérôme Langlade
Investment Director Aquitaine / Limousin / Poitou-Charentes
Eric Lefebvre
Director
Stephane Lefevre-Sauli
Senior Investment Director
Arnaud Legardeur
Investment Director
Olivier Martinez
Investment Director
Serge Mesguich
Director of FIT
Louis Molis
Investment Director
Jean-Francois Morin
Investment Director
Sébastien Moynot
Director
Adrien Muller
Investment Director
Adrien Neel
Investment Director
Axel Piriou
Director of Investments
Olivier Rameil
Senior Investment Director / VC seed
Vincent Roque
Director
Thibaut Roulon Ph.D
Investment Director
Gilles Schang
Deputy Managing Director
Bruno Villeneuve
Associate
Jean-Marie Fougeray
Senior Investment Director, Brittany
Laure Michel
Investment Director
Past deals in Nanotechnology
Superbranche
Venture Round in 2025
SUPERBRANCHE is a biotechnology company focused on the early detection and treatment of metastases using advanced nanotechnology. The company develops therapeutic and diagnostic applications that aim to enhance accessibility and facilitate the timely identification of tumors. Its innovative platform incorporates targeted diagnostic and image-guided therapy nanomaterials, grounded in proprietary technology. This approach enables healthcare providers to detect and address metastases earlier, ultimately improving patient outcomes.
Vulkam
Debt Financing in 2023
Vulkam SAS is a microtechnology company based in Saint-Martin-d'Hères, France, that specializes in the design, development, and production of amorphous metal parts. Founded in 2017, Vulkam utilizes biocompatible amorphous metal alloys primarily composed of materials such as zirconium, copper, hafnium, nickel, and titanium. The company's innovative products find applications across various industries, including aerospace, automotive, biomedical, cryogenic, watches, jewellery, and micro components. Vulkam's focus on creating micromechanical parts that are significantly smaller yet maintain strength and functionality sets a new standard in metallurgy and metal processing, positioning the company as a leader in the development of advanced metal technologies.
Vulkam
Venture Round in 2023
Vulkam SAS is a microtechnology company based in Saint-Martin-d'Hères, France, that specializes in the design, development, and production of amorphous metal parts. Founded in 2017, Vulkam utilizes biocompatible amorphous metal alloys primarily composed of materials such as zirconium, copper, hafnium, nickel, and titanium. The company's innovative products find applications across various industries, including aerospace, automotive, biomedical, cryogenic, watches, jewellery, and micro components. Vulkam's focus on creating micromechanical parts that are significantly smaller yet maintain strength and functionality sets a new standard in metallurgy and metal processing, positioning the company as a leader in the development of advanced metal technologies.
Quandela
Series B in 2023
Quandela is a company specializing in quantum computing, focusing on the development of communication networks and optical computers. It manufactures photonic quantum computers and markets them to industrial clients. The company's flagship product, a single-photon source device, integrates photonics with semiconductor quantum dots, facilitating quantum communication, computation, and sensing. This device allows for the efficient collection of emitted single photons at high rates, helping researchers minimize charge noise decoherence and achieve the emission of identical photons with high fidelity. These advancements are crucial for the progress of sophisticated quantum applications, positioning Quandela as a key player in the field of quantum technology.
Hummink
Seed Round in 2022
Hummink is a Paris-based company founded in 2020 that specializes in additive manufacturing technology focused on nanoscale design and production. The company utilizes a patented technology that integrates a nanometric pen with an oscillating microresonator to achieve capillary deposition of various liquids. This innovative approach allows clients in the semiconductor and molecular diagnostic industries to create large objects while maintaining high resolution and precision on substrates ranging from millimetric to centimetric scales. Hummink's advancements in nano-printing technology position it as a valuable player in the field of precision manufacturing.
Scintil Photonics
Venture Round in 2022
SCINTIL Photonics is a fabless company that develops silicon photonic integrated circuits. SCINTIL solutions combine the best of Silicon (Si) and Indium Phosphide (InP) materials using wafer-scale bonding of InP on Si and rely on commercial silicon foundry processes to build fully integrated photonic circuits (comprising multi-wavelength lasers, waveguides, wavelength filters, and photodetectors).
NAWA Technologies
Series C in 2022
NAWA Technologies focuses on developing innovative energy solutions through its Ultra Fast Carbon Battery Technology, which utilizes carbon as a primary material due to its abundance and accessibility. Established in April 2013, the company is dedicated to enhancing energy conversion, storage, and efficiency while minimizing environmental impacts through sustainable manufacturing processes. With over 15 years of research and development in nanomaterials, NAWA Technologies has built a pilot production line and employs a team of 24 professionals. Its products, including advanced ultracapacitors and battery electrodes, are designed to facilitate the integration of renewable energy into smart grids, promoting efficient electricity storage and reducing carbon emissions associated with fossil fuel usage.
Quandela
Venture Round in 2021
Quandela is a company specializing in quantum computing, focusing on the development of communication networks and optical computers. It manufactures photonic quantum computers and markets them to industrial clients. The company's flagship product, a single-photon source device, integrates photonics with semiconductor quantum dots, facilitating quantum communication, computation, and sensing. This device allows for the efficient collection of emitted single photons at high rates, helping researchers minimize charge noise decoherence and achieve the emission of identical photons with high fidelity. These advancements are crucial for the progress of sophisticated quantum applications, positioning Quandela as a key player in the field of quantum technology.
Grapheal
Seed Round in 2021
Grapheal is a Medtech startup focused on developing embedded and wearable biosensors that leverage graphene transistors for enhanced functionality. Their devices are designed to be minimalistic and digital, enabling the dosing of biomarkers and detection of pathogens through a smartphone interface. By integrating advanced sensing nanomaterials with wireless connectivity and data analysis capabilities, Grapheal's biosensors facilitate field diagnostics and remote patient monitoring. This approach aims to make healthcare more accessible and accurate, allowing medical professionals to effectively monitor patient progress and healing.
NAWA Technologies
Venture Round in 2020
NAWA Technologies focuses on developing innovative energy solutions through its Ultra Fast Carbon Battery Technology, which utilizes carbon as a primary material due to its abundance and accessibility. Established in April 2013, the company is dedicated to enhancing energy conversion, storage, and efficiency while minimizing environmental impacts through sustainable manufacturing processes. With over 15 years of research and development in nanomaterials, NAWA Technologies has built a pilot production line and employs a team of 24 professionals. Its products, including advanced ultracapacitors and battery electrodes, are designed to facilitate the integration of renewable energy into smart grids, promoting efficient electricity storage and reducing carbon emissions associated with fossil fuel usage.
Vulkam
Grant in 2020
Vulkam SAS is a microtechnology company based in Saint-Martin-d'Hères, France, that specializes in the design, development, and production of amorphous metal parts. Founded in 2017, Vulkam utilizes biocompatible amorphous metal alloys primarily composed of materials such as zirconium, copper, hafnium, nickel, and titanium. The company's innovative products find applications across various industries, including aerospace, automotive, biomedical, cryogenic, watches, jewellery, and micro components. Vulkam's focus on creating micromechanical parts that are significantly smaller yet maintain strength and functionality sets a new standard in metallurgy and metal processing, positioning the company as a leader in the development of advanced metal technologies.
Scintil Photonics
Seed Round in 2019
SCINTIL Photonics is a fabless company that develops silicon photonic integrated circuits. SCINTIL solutions combine the best of Silicon (Si) and Indium Phosphide (InP) materials using wafer-scale bonding of InP on Si and rely on commercial silicon foundry processes to build fully integrated photonic circuits (comprising multi-wavelength lasers, waveguides, wavelength filters, and photodetectors).
NH TherAguix
Series A in 2019
NH TherAguix SAS is a clinical stage pharmaceutical company based in Villeurbanne, France, focused on developing nanomedicines for cancer treatment, specifically utilizing radiotherapy. The company's lead product, AGuIX, is a theranostic nanoparticle designed to enhance the localization of solid tumors and improve the effectiveness of radiation therapy. AGuIX allows for the determination of optimal irradiation timing and is capable of treating radioresistant cancers while minimizing radiation exposure to healthy tissues, thereby reducing secondary effects. Founded in 2015, NH TherAguix is dedicated to advancing innovative solutions in cancer care through its pioneering research and development efforts.
Nanobiotix
Grant in 2013
Nanobiotix SA develops nanomedicine programs for the treatment of cancer. The company provides NanoXray that offers a solution for cancer therapy based on a technology that is designed to allow destruction of cancer cells by inert particles. Its products include magnetic particles and laser activated nanoparticles for the treatment and diagnostic of cancer.
Nanobiotix
Series E in 2013
Nanobiotix SA develops nanomedicine programs for the treatment of cancer. The company provides NanoXray that offers a solution for cancer therapy based on a technology that is designed to allow destruction of cancer cells by inert particles. Its products include magnetic particles and laser activated nanoparticles for the treatment and diagnostic of cancer.
Nanobiotix
Seed Round in 2005
Nanobiotix SA develops nanomedicine programs for the treatment of cancer. The company provides NanoXray that offers a solution for cancer therapy based on a technology that is designed to allow destruction of cancer cells by inert particles. Its products include magnetic particles and laser activated nanoparticles for the treatment and diagnostic of cancer.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.